Aeovian Pharmaceuticals
PrivateLast Round
Series B
Dec 16, 2025
Total Funding Raised
$142M
Company Overview
Aeovian Pharmaceuticals is a biotechnology company focused on developing innovative therapeutics aimed at treating rare and age-related diseases by targeting the underlying causes of disease initiation and progression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aeovian Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Aeovian Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 16, 2025 | ||||
| Series A Extension | Mar 28, 2024 | ||||
| Series A | Oct 3, 2019 | ||||
| Seed | Dec 11, 2017 |
Aeovian Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apollo Ventures | Seed |
| SymBiosis Capital Management | Series B |
| CTI Life Sciences Fund | Series B |
| TSC Alliance Endowment Fund | Series B |
| Hevolution Foundation | Series B, Series A Extension |
| LUMA Partners | Series B |
| Foresite Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
$55M Series B round completed.
- Dec 16, 2025
Youssef Bennani joins the Board of Directors.
Aeovian Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aeovian Pharmaceuticals's valuation, stock price, and market status.
